Both in Pharmaceuticals
Galectin Therapeutics vs Opus Genetics
Over the past year GALT returned −44.7% and IRD returned +71.5%; their daily moves had a correlation of 0.05.
GALT −44.7% IRD +71.5%Growth of $1, one year, split-adjusted
| Metric | GALT | IRD |
|---|---|---|
| Price | $3.32 | $3.67 |
| Market cap | $334.8M | $305.3M |
| Today | −5.68% | +0.55% |
| 1 month | −11.7% | −18.6% |
| 6 months | +46.3% | −28.6% |
| Year to date | −20.2% | +82.6% |
| 1 year | −35.0% | +85.4% |
| Revenue growth (YoY) | — | −73.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1072.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 31.0× |
| Net cash | -$19.8M | $53.9M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 91.9% |
| Short % of float | 13.7% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).